Sitemap - 2025 - Where Tech Meets Bio
Weekly Tech+Bio Highlights #47: Microsoft AI's Diagnostic Multi-Agent Orchestrator
Emerging Brain-Computer Interface Industry Across Chips, AI, and Regulation
Weekly Tech+Bio Highlights #46: New DeepMind AI Predicts How Genes Work
Weekly Tech+Bio Highlights #45: Biotech Funding Reset & What Workers Actually Want from AI Agents
12 Startups Applying AI to Gene Editing: From Custom CRISPR to Zinc-Finger Revivals
Weekly Tech+Bio Highlights #44: New 9.8 Billion Protein Dataset Built for Generative Biology
Weekly Tech+Bio Highlights #43: New Foundation Model from MIT & Recursion
17 More Biomedical Foundation Models
Weekly Tech+Bio Highlights #42: Proteins, the Universe, and Everything
14 Startups in AI Protein Design: Platforms, Specialists, Modular Tools
Weekly Tech+Bio Highlights #41: Fortnight Overview
AI Meets Clinical Trials: Recent Policy Shifts & Companies to Watch
Weekly Tech+Bio Highlights #40: FDA Sets Deadline for Internal AI Rollout
Weekly Tech+Bio Highlights #39: Towards Human-Based Models
The Infrastructure Layer: Platforms Powering Human-Relevant Drug Development
Weekly Tech+Bio Highlights #38: Predictive Models & Benchmarks
Weekly Tech+Bio Highlights #37: Turning Cells Into Language
23 New Startups in AI Drug Development Space Launched 2023–2025
Weekly Tech+Bio Highlights #36: Defining Modern AI Drug Discovery
The Rise of AI Agents in Biotech, Where Are We Now?
Weekly Tech+Bio Highlights #35: Reading the Inflection Points of AI Drug Development
Weekly Tech+Bio Highlights #34
13 Foundation Models: Startups, Industry Updates and the Nobel Prize
Weekly Tech+Bio Highlights #33: The "Holy Grail" of Digital Biology
12 Startups in the Digital Twin Healthcare Ecosystem: From Virtual Organs to Optimized Trials
Weekly Tech+Bio Highlights #32: Chemical Lab Run by Multi-Agent AI
Next Generation Sequencing: New Tech and Companies to Watch
Weekly Tech+Bio Highlights #31: Synthetic Biological Intelligence, China’s Growing Role In BCI
How Clinical Trial Design Choices Impact Speed, Risk, and Regulatory Outcomes?
Weekly Tech+Bio Highlights #30: Roche’s Comeback to Sequencing
Weekly Tech+Bio Highlights #29
Weekly Tech+Bio Highlights #28
Weekly Tech+Bio Highlights #27
Disarming Cancer's Immune Evasion, Owkin Doses First Patient With AI-Optimized Therapy
Lantern Pharma Introduces AI-Driven Antibody-Drug Conjugate Development
Moderna’s Co-Founder Links the US & UK Cambridges in Research Collaboration
Basetwo Raises $11.5M for AI-Driven, First-Principles Pharmaceutical Manufacturing Optimization
Insilico Medicine Doses First Patient With AI-Designed Pan-TEAD Inhibitor
Weekly Tech+Bio Highlights #26
FDA’s AI Drug Development Guidelines and What’s Next for Biopharma M&A